Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow in hairy cell leukemia.

I Katayama1

  • 1Department of Pathology, Saitama Medical School, Japan.

Hematology/Oncology Clinics of North America
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Hairy cell leukemia (HCL) presents with varied clinical signs, but its bone marrow pathology is consistently characteristic. Bone marrow biopsy is crucial for diagnosing HCL and guiding treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is the origin of macroscopic friction?

Science advances·2018
Same author

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

The British journal of dermatology·2018
Same author

Novel autoantibody against the β2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers.

The British journal of dermatology·2017
Same author

Value of ultrasonography findings for nail psoriasis before and after adalimumab administration.

Clinical and experimental dermatology·2017
Same author

Anti-RNA polymerase III antibody positive limited cutaneous systemic sclerosis with cryoglobulin-induced digital gangrene.

Clinical and experimental dermatology·2016
Same author

A gas circulation and purification system for gas-cell-based low-energy RI-beam production.

The Review of scientific instruments·2016
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Hairy cell leukemia (HCL) is a recognized lymphoproliferative disorder.
  • HCL exhibits significant variability in clinical and hematologic presentations, leading to proposed subtypes.
  • Despite clinical diversity, the pathology of HCL in the spleen and bone marrow is highly characteristic.

Purpose of the Study:

  • To highlight the consistent bone marrow pathology in HCL.
  • To emphasize the diagnostic importance of bone marrow examination in HCL.
  • To underscore the role of bone marrow biopsy in HCL management and pathogenesis research.

Main Methods:

  • Review of pathological findings in HCL, focusing on bone marrow.
  • Analysis of diagnostic criteria based on bone marrow morphology.

Related Experiment Videos

  • Consideration of bone marrow's role in therapeutic selection and monitoring.

    • Main Results:

    • HCL bone marrow pathology is characterized by mononuclear cell infiltration with wide nuclear spacing or by hypocellular marrow with individual hairy cells.
    • Bone marrow biopsy is critical for differential diagnosis, especially when spleen examination is unavailable.
    • Bone marrow findings are essential for therapeutic decisions and treatment response assessment.

    Conclusions:

    • Bone marrow pathology provides a consistent diagnostic hallmark for Hairy Cell Leukemia.
    • Bone marrow biopsy is indispensable for accurate HCL diagnosis, treatment selection, and monitoring.
    • Ongoing research into the bone marrow microenvironment offers new insights into HCL pathogenesis.